CoreWeave in advanced talks to acquire Core Scientific following rejected bid: report

CoreWeave is reportedly in advanced negotiations to acquire Core Scientific, following a previously rejected $5.75 per share bid. This potential acquisition has propelled Core Scientific shares over 40% this week to approximately $16, valuing the company near $5 billion, significantly above CoreWeave's earlier offer, while CoreWeave's stock declined 11%. Analysts support the deal, noting both firms' transition from crypto mining to AI datacenter operations and the potential for Core Scientific's infrastructure to offer immediate value to CoreWeave.

Analysis

CoreWeave is in advanced negotiations to acquire Core Scientific, signaling a potentially significant consolidation in the AI datacenter space. This follows a previously rejected bid of $5.75 per share, which the market now views as substantially undervalued. The market reaction has been starkly divergent: Core Scientific's (CORZ) shares surged over 40% to approximately $16, pushing its market capitalization towards $5 billion, while CoreWeave's (CRWV) shares fell by 11%. This price action indicates strong investor optimism for a high-premium buyout for CORZ, but also reflects concern from CRWV investors about the potential cost of the acquisition. The strategic rationale for the deal, as highlighted by Wedbush analysts, is compelling, rooted in the similar operational pivots both companies have made from cryptocurrency mining to supporting AI workloads. The analysis suggests that Core Scientific's existing infrastructure, potentially including high-end graphics cards, could offer immediate and substantial value to CoreWeave's operations, particularly for processes like AI token generation.

Key Decisions for Investors

• Investors in Core Scientific should recognize that the stock's recent 40% surge has priced in significant acquisition expectations, and the primary risk is a sharp pullback if negotiations with CoreWeave fail.
• For those holding CoreWeave, the 11% share price decline signals market apprehension over the potential acquisition cost, and any finalized deal will need to demonstrate clear, immediate synergies to justify the likely high premium required to acquire Core Scientific.
• The proposed acquisition underscores the strategic value of repurposing crypto-mining infrastructure for AI, suggesting investors should evaluate other firms in the sector for similar asset value and potential M&A activity.